A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice

Study Purpose

The purpose of the study is to assess the effectiveness of certolizumab pegol in patients with moderate to severe plaque psoriasis as part of routine clinical practice.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - The patient is ≥18 years of age at observational point 1.
  • - The patient must have a clinical diagnosis of moderate to severe Plaque psoriasis according to the diagnostic criteria used by the physician in routine clinical practice.
  • - The patient has an available PASI assessment prior to the first certolizumab pegol dose according to the standard of care.
  • - The patient must be newly prescribed with certolizumab pegol.
  • - If a patient is participating in an ongoing investigational study, then he/she will not be able to take part in this study.

Exclusion Criteria:

Not applicable

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT04053881
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

UCB Biopharma SRL
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

UCB Cares
Principal Investigator Affiliation 001 844 599 2273 (UCB)
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Industry
Overall Status Recruiting
Countries Belgium, Canada, Czechia, France, Germany, Greece, Italy, Spain, United Kingdom
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Plaque Psoriasis
Arms & Interventions

Arms

: Certolizumab pegol

Plaque psoriasis patients who have been newly prescribed certolizumab pegol (CZP).

Interventions

Drug: - Certolizumab pegol

Active Substance: Certolizumab Pegol Pharmaceutical Form: Prefilled syringe Concentration: 200 mg/ml Route of Administration: Subcutaneous injection

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

Ps0026 107, Brussels, Belgium

Status

Recruiting

Address

Ps0026 107

Brussels, ,

Ps0026 101, Bruxelles, Belgium

Status

Recruiting

Address

Ps0026 101

Bruxelles, ,

Ps0026 103, Bruxelles, Belgium

Status

Recruiting

Address

Ps0026 103

Bruxelles, ,

Ps0026 105, Charleroi, Belgium

Status

Recruiting

Address

Ps0026 105

Charleroi, ,

Ps0026 108, Lede, Belgium

Status

Recruiting

Address

Ps0026 108

Lede, ,

Ps0026 102, Leuven, Belgium

Status

Recruiting

Address

Ps0026 102

Leuven, ,

Ps0026 110, Maldegem, Belgium

Status

Recruiting

Address

Ps0026 110

Maldegem, ,

Ps0026 109, Mons, Belgium

Status

Recruiting

Address

Ps0026 109

Mons, ,

Ps0026 104, Namur, Belgium

Status

Recruiting

Address

Ps0026 104

Namur, ,

Ps0026 208, London, Canada

Status

Recruiting

Address

Ps0026 208

London, ,

Ps0026 209, London, Canada

Status

Recruiting

Address

Ps0026 209

London, ,

Ps0026 201, Markham, Canada

Status

Recruiting

Address

Ps0026 201

Markham, ,

Ps0026 210, Newmarket, Canada

Status

Recruiting

Address

Ps0026 210

Newmarket, ,

Ps0026 203, Saint John's, Canada

Status

Recruiting

Address

Ps0026 203

Saint John's, ,

Ps0026 212, Toronto, Canada

Status

Recruiting

Address

Ps0026 212

Toronto, ,

Ps0026 211, Vancouver, Canada

Status

Recruiting

Address

Ps0026 211

Vancouver, ,

Ps0026 205, Waterloo, Canada

Status

Recruiting

Address

Ps0026 205

Waterloo, ,

Ps0026 204, Winnipeg, Canada

Status

Recruiting

Address

Ps0026 204

Winnipeg, ,

Ps0026 301, Praha, Czechia

Status

Recruiting

Address

Ps0026 301

Praha, ,

Ps0026 303, Praha, Czechia

Status

Recruiting

Address

Ps0026 303

Praha, ,

Ps0026 302, Uherské Hradiště, Czechia

Status

Recruiting

Address

Ps0026 302

Uherské Hradiště, ,

Ps0026 408, Amiens, France

Status

Recruiting

Address

Ps0026 408

Amiens, ,

Ps0026 402, Limoges, France

Status

Recruiting

Address

Ps0026 402

Limoges, ,

Ps0026 404, Lorient, France

Status

Recruiting

Address

Ps0026 404

Lorient, ,

Ps0026 405, Paris, France

Status

Recruiting

Address

Ps0026 405

Paris, ,

Ps0026 409, Poitiers, France

Status

Recruiting

Address

Ps0026 409

Poitiers, ,

Ps0026 403, Rennes, France

Status

Recruiting

Address

Ps0026 403

Rennes, ,

Ps0026 407, Toulon, France

Status

Recruiting

Address

Ps0026 407

Toulon, ,

Ps0026 503, Bergen auf Rügen, Germany

Status

Recruiting

Address

Ps0026 503

Bergen auf Rügen, ,

Ps0026 512, Bielefeld, Germany

Status

Recruiting

Address

Ps0026 512

Bielefeld, ,

Ps0026 532, Bogen, Germany

Status

Recruiting

Address

Ps0026 532

Bogen, ,

Ps0026 528, Bremen, Germany

Status

Recruiting

Address

Ps0026 528

Bremen, ,

Ps0026 525, Dresden, Germany

Status

Recruiting

Address

Ps0026 525

Dresden, ,

Ps0026 506, Düren, Germany

Status

Recruiting

Address

Ps0026 506

Düren, ,

Ps0026 536, Falkensee, Germany

Status

Recruiting

Address

Ps0026 536

Falkensee, ,

Ps0026 521, Freiburg, Germany

Status

Recruiting

Address

Ps0026 521

Freiburg, ,

Ps0026 524, Gera, Germany

Status

Recruiting

Address

Ps0026 524

Gera, ,

Ps0026 529, Gladbeck, Germany

Status

Recruiting

Address

Ps0026 529

Gladbeck, ,

Ps0026 523, Hamburg, Germany

Status

Recruiting

Address

Ps0026 523

Hamburg, ,

Ps0026 518, Karlsruhe, Germany

Status

Recruiting

Address

Ps0026 518

Karlsruhe, ,

Ps0026 533, Koblenz, Germany

Status

Recruiting

Address

Ps0026 533

Koblenz, ,

Ps0026 508, Langenau, Germany

Status

Recruiting

Address

Ps0026 508

Langenau, ,

Ps0026 519, Leipzig, Germany

Status

Recruiting

Address

Ps0026 519

Leipzig, ,

Ps0026 514, Magdeburg, Germany

Status

Recruiting

Address

Ps0026 514

Magdeburg, ,

Ps0026 537, Magdeburg, Germany

Status

Recruiting

Address

Ps0026 537

Magdeburg, ,

Ps0026 530, Memmingen, Germany

Status

Recruiting

Address

Ps0026 530

Memmingen, ,

Ps0026 516, Merzig, Germany

Status

Recruiting

Address

Ps0026 516

Merzig, ,

Ps0026 517, München, Germany

Status

Recruiting

Address

Ps0026 517

München, ,

Ps0026 527, München, Germany

Status

Recruiting

Address

Ps0026 527

München, ,

Ps0026 526, Neuwied, Germany

Status

Recruiting

Address

Ps0026 526

Neuwied, ,

Ps0026 515, Nürnberg, Germany

Status

Terminated

Address

Ps0026 515

Nürnberg, ,

Ps0026 501, Potsdam, Germany

Status

Recruiting

Address

Ps0026 501

Potsdam, ,

Ps0026 511, Quedlinburg, Germany

Status

Recruiting

Address

Ps0026 511

Quedlinburg, ,

Ps0026 505, Remscheid, Germany

Status

Recruiting

Address

Ps0026 505

Remscheid, ,

609 Ps0026, Athens, Greece

Status

Recruiting

Address

609 Ps0026

Athens, ,

Ps0026 603, Athens, Greece

Status

Recruiting

Address

Ps0026 603

Athens, ,

Ps0026 610, Athens, Greece

Status

Recruiting

Address

Ps0026 610

Athens, ,

Ps0026 601, Chaïdári, Greece

Status

Recruiting

Address

Ps0026 601

Chaïdári, ,

Ps0026 606, Larissa, Greece

Status

Recruiting

Address

Ps0026 606

Larissa, ,

Ps0026 608, Patras, Greece

Status

Recruiting

Address

Ps0026 608

Patras, ,

Ps0026 607, Piraeus, Greece

Status

Recruiting

Address

Ps0026 607

Piraeus, ,

Ps0026 604, Thessaloníki, Greece

Status

Recruiting

Address

Ps0026 604

Thessaloníki, ,

Ps0026 605, Thessaloníki, Greece

Status

Recruiting

Address

Ps0026 605

Thessaloníki, ,

Ps0026 707, Bari, Italy

Status

Recruiting

Address

Ps0026 707

Bari, ,

Ps0026 711, Brescia, Italy

Status

Recruiting

Address

Ps0026 711

Brescia, ,

Ps0026 710, Firenze, Italy

Status

Recruiting

Address

Ps0026 710

Firenze, ,

Ps0026 702, Genova, Italy

Status

Recruiting

Address

Ps0026 702

Genova, ,

Ps0026 706, L'Aquila, Italy

Status

Recruiting

Address

Ps0026 706

L'Aquila, ,

Ps0026 701, Napoli, Italy

Status

Recruiting

Address

Ps0026 701

Napoli, ,

Ps0026 709, Roma, Italy

Status

Recruiting

Address

Ps0026 709

Roma, ,

Ps0026 713, Roma, Italy

Status

Recruiting

Address

Ps0026 713

Roma, ,

Ps0026 715, Torino, Italy

Status

Recruiting

Address

Ps0026 715

Torino, ,

Ps0026 807, Badalona, Spain

Status

Recruiting

Address

Ps0026 807

Badalona, ,

Ps0026 809, Barcelona, Spain

Status

Recruiting

Address

Ps0026 809

Barcelona, ,

Ps0026 811, Barcelona, Spain

Status

Recruiting

Address

Ps0026 811

Barcelona, ,

Ps0026 812, Barcelona, Spain

Status

Recruiting

Address

Ps0026 812

Barcelona, ,

Ps0026 804, Pontevedra, Spain

Status

Recruiting

Address

Ps0026 804

Pontevedra, ,

Ps0026 806, Sant Joan Despí, Spain

Status

Recruiting

Address

Ps0026 806

Sant Joan Despí, ,

Ps0026 902, Bradford, United Kingdom

Status

Recruiting

Address

Ps0026 902

Bradford, ,

Ps0026 910, Dumfries, United Kingdom

Status

Recruiting

Address

Ps0026 910

Dumfries, ,

Ps0026 909, Dunfermline, United Kingdom

Status

Recruiting

Address

Ps0026 909

Dunfermline, ,

Ps0026 914, Glasgow, United Kingdom

Status

Recruiting

Address

Ps0026 914

Glasgow, ,

Ps0026 911, Kingston Upon Thames, United Kingdom

Status

Recruiting

Address

Ps0026 911

Kingston Upon Thames, ,

Ps0026 907, London, United Kingdom

Status

Recruiting

Address

Ps0026 907

London, ,

Ps0026 904, Newcastle Upon Tyne, United Kingdom

Status

Recruiting

Address

Ps0026 904

Newcastle Upon Tyne, ,

Ps0026 901, Salford, United Kingdom

Status

Recruiting

Address

Ps0026 901

Salford, ,

Ps0026 912, Slough, United Kingdom

Status

Recruiting

Address

Ps0026 912

Slough, ,

Ps0026 915, Wakefield, United Kingdom

Status

Recruiting

Address

Ps0026 915

Wakefield, ,

Ps0026 908, York, United Kingdom

Status

Recruiting

Address

Ps0026 908

York, ,

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation.